These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25645342)

  • 21. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy.
    Li S; Wang L; Zhang M; Zhou W; Fang W; Wang Q; Qi C; Mou S; Shao X; Ni Z
    Nephron; 2017; 135(2):87-96. PubMed ID: 27974710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy?
    Goumenos DS
    Expert Opin Pharmacother; 2008 Jul; 9(10):1695-704. PubMed ID: 18570603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
    Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.
    Lin S; Li HY; Zhou T; Lin W
    Drug Des Devel Ther; 2019; 13():2305-2330. PubMed ID: 31371924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
    Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathy.
    Shin DH; Lee MJ; Oh HJ; Koo HM; Doh FM; Kim HR; Han JH; Park JT; Han SH; Choi KH; Yoo TH; Kang SW
    Yonsei Med J; 2013 Jul; 54(4):973-82. PubMed ID: 23709434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
    Cao Q; Huang WY; Xu H; Zhou LJ
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):698-701. PubMed ID: 19099862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.
    Cattran DC
    Semin Nephrol; 2003 May; 23(3):272-7. PubMed ID: 12838495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
    Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
    Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
    Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
    Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complete remission of repeated recurrent membranous nephropathy after non-myeloablative allogeneic peripheral blood stem cell transplantation].
    Matsuura T; Hiramoto N; Iwasa T; Shoji M; Ohashi K
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1327-34. PubMed ID: 24288970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy.
    Kim Y; Yoon HE; Chung BH; Choi BS; Park CW; Yang CW; Kim YS; Hong YA; Kim SY; Chang YK; Hwang HS
    Korean J Intern Med; 2019 Sep; 34(5):1091-1099. PubMed ID: 31408925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy.
    Li MX; Yu YW; Zhang ZY; Zhao HD; Xiao FL
    Genet Mol Res; 2015 Mar; 14(1):2665-73. PubMed ID: 25867415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.